S
Sundar Jagannath
Researcher at Mount Sinai Hospital
Publications - 19
Citations - 546
Sundar Jagannath is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Multiple myeloma & Bortezomib. The author has an hindex of 5, co-authored 19 publications receiving 497 citations. Previous affiliations of Sundar Jagannath include New York Medical College.
Papers
More filters
Journal ArticleDOI
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
Glen S. Markowitz,Gerald B. Appel,Paul L. Fine,Andrew Z. Fenves,Nicholas R. Loon,Sundar Jagannath,Joseph A. Kuhn,Adam D. Dratch,Vivette D. D'Agati +8 more
TL;DR: The temporal association between pamidronate therapy and the development of renal insufficiency, the use of escalating doses that exceed recommended levels, and the distinctive pattern of glomerular andtubular injury strongly suggest a mechanism of drug-associated podocyte and tubular toxicity.
Journal ArticleDOI
The Current Status and Future of Multiple Myeloma in the Clinic
Sundar Jagannath,Robert A. Kyle,Antonio Palumbo,David S. Siegel,Sonia Cunningham,James R. Berenson +5 more
TL;DR: Challenges in the clinic and newer approaches under evaluation for the treatment and/or management of patients with MGUS, SMM, and MM are highlighted.
Journal ArticleDOI
Intracranial Multifocal Dural Involvement in Multiple Myeloma: Case Report and Review of the Literature
Carlos E. Méndez,Becky J. Hwang,Sylvie Destian,Amitabha Mazumder,Sundar Jagannath,David H. Vesole +5 more
TL;DR: There are no established treatment guidelines for CNS myelomatosis; prognosis and literature on the use of treatment modalities for this complication is reviewed herein.
Journal ArticleDOI
Thalidomide and lenalidomide in multiple myeloma
TL;DR: The immunomodulatory function of these drugs can be successfully exploited to control residual disease during remission and ushered in a new era of optimism in the management of this incurable cancer.
Journal ArticleDOI
Plasmacytoma in the breast with axillary lymph node involvement: a case report.
TL;DR: This could be the first recorded account of plasmacytomas in the breast with axillary lymph node involvement and extracapsular extension of tumor.